Bloomberg Markets: Using Facial Images to Diagnose Diseases

April 24, 2017

Bloomberg 

“Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Dekel Gelbman Chief Executive Officer FDNA Discussing the Face2Gene app that is diagnosing rare genetic diseases.”

 

The Bloomberg Markets podcast discusses how Face2Gene utilizes facial image analysis to diagnose diseases. By employing advanced artificial intelligence, Face2Gene analyzes facial features from photographs to detect markers associated with various genetic disorders. This technology aids healthcare professionals in making quicker, more accurate preliminary diagnoses, especially in regions with limited access. FDNA’s engagement tool for geneticists is a comprehensive, patient-centric online platform that streamlines access to diagnostic services. It enhances the intake process, enabling genetic specialists to see more qualified patients. Through an AI-based initial assessment, including facial analysis, patients are connected with genetic experts based on their evaluation results. The podcast highlights the potential of facial image analysis to revolutionize medical diagnostics, making genetic disorder detection more accessible and efficient.